Advertisement

The Scientist

» clinical trials and microbiology

Most Recent

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

1 Comment

image: The Energy of Life

The Energy of Life

By | February 1, 2015

Extremophiles should not be viewed through an anthropocentric lens; what’s extreme for us may be a perfectly comfortable environment for a microbe.

3 Comments

image: Tamiflu Reviewed Again

Tamiflu Reviewed Again

By | January 30, 2015

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

1 Comment

image: UV Light Doesn’t Fully Purify

UV Light Doesn’t Fully Purify

By | January 28, 2015

Using ultraviolet light to disinfect drinking water may simply drive bacteria to dormancy, rather than kill them.

0 Comments

image: Ebola Update

Ebola Update

By | January 26, 2015

Vaccine trial to start in Liberia as early as next week; trial for experimental therapy also planned, but production is still limited

1 Comment

image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.

6 Comments

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

Advertisement

Popular Now

  1. Staying Active in the Lab
    Careers Staying Active in the Lab

    Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

  2. When Does a Smart Mouse Become Human?
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. Antibiotic Resistance Can Boost Bacterial Fitness
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist